78 related articles for article (PubMed ID: 2164202)
1. [Nerve conduction velocity following high-dose vincristine in the treatment of small cell bronchial cancer].
Eich F; Emser W; Sybrecht GW
Pneumologie; 1990 Feb; 44 Suppl 1():574-5. PubMed ID: 2164202
[TBL] [Abstract][Full Text] [Related]
2. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
Unsal M; Erturk D
Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
[TBL] [Abstract][Full Text] [Related]
4. [Small cell bronchial cancer. Comparison of results of weekly polychemotherapy using multiple drugs with standard chemotherapy. European Lung Cancer Working Party].
Sculier JP; Paesmans M; Bureau G; Dabouis G; Libert P; Vandermoten G; Van Cutsem O; Berchier MC; Ries F; Michel J
Rev Mal Respir; 1994; 11(3):257-61. PubMed ID: 8041988
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy of small cell lung cancer].
Komiya T; Takada M
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1116-23. PubMed ID: 8751797
[TBL] [Abstract][Full Text] [Related]
6. Sequential high dose-density chemotherapy with two active regimens for advanced small cell lung cancer.
Vigani A; Pensa F; Vaira F; Bancalari L; Cordani S; Maggiani R; Canessa P; Pronzato P
Anticancer Res; 2000; 20(5C):4015-8. PubMed ID: 11268494
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin and etoposide alternating with vincristine, doxorubicin and cyclophosphamide in patients with small cell lung cancer.
Littlewood TJ; Smith AP; Anderson G; Chappell AG; James KW
Eur J Respir Dis; 1985 Oct; 67(4):294-300. PubMed ID: 3000808
[TBL] [Abstract][Full Text] [Related]
8. [Phase II study with etoposide/vincristine in small cell bronchial cancer (extensive disease)].
von Pawel J; Wilke H; Vallée D; Dimbeck H; Schmoll HJ
Pneumologie; 1990 Feb; 44 Suppl 1():582-3. PubMed ID: 1695002
[TBL] [Abstract][Full Text] [Related]
9. Treatment of small cell lung cancer: experience at Maharaj Nakhon Chiang Mai Hospital.
Thongprasert S; Jiemsripong K; Phothirat C; Atikachai B
J Med Assoc Thai; 1991 May; 74(5):253-6. PubMed ID: 1664446
[No Abstract] [Full Text] [Related]
10. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L
Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
[TBL] [Abstract][Full Text] [Related]
11. Dose-intensive weekly alternating chemotherapy for patients with small cell lung cancer: randomized trial, can it improve survival of patients with good prognostic factors?
Masutani M; Ochi Y; Kadota A; Akusawa H; Kisohara A; Takahashi N; Koya Y; Horie T
Oncol Rep; 2000; 7(2):305-10. PubMed ID: 10671676
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
Ueoka H; Kiura K; Tabata M; Kamei H; Gemba K; Sakae K; Hiraki Y; Hiraki S; Segawa Y; Harada M
Cancer; 1998 Jul; 83(2):283-90. PubMed ID: 9669811
[TBL] [Abstract][Full Text] [Related]
13. Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer.
Lindgren D; Cadman E; Erichson R; Grann V; Sachs K
Cancer Treat Rep; 1984 Sep; 68(9):1159-61. PubMed ID: 6090015
[TBL] [Abstract][Full Text] [Related]
14. [Dose-response effect of drugs in the chemotherapy of small-cell bronchial carcinoma].
Kostić D; Jelić S; Radulović S
Srp Arh Celok Lek; 2000; 128(3-4):75-9. PubMed ID: 10932613
[TBL] [Abstract][Full Text] [Related]
15. [The role of surgical treatment in the combination therapy of small cell lung cancer (SCLC)].
Yamaguchi Y; Momiki S; Kimura H; Ogawa T; Baba M
Kyobu Geka; 1988 Mar; 41(3):184-9. PubMed ID: 2838669
[No Abstract] [Full Text] [Related]
16. [Multidisciplinary treatment for small cell lung cancer].
Saijo N; Eguchi K; Shimizu E; Shinkai T; Tominaga K; Takahashi K; Sasaki Y; Seki S
Gan To Kagaku Ryoho; 1984 Mar; 11(3):474-9. PubMed ID: 6322700
[TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer.
Shepherd FA; Evans WK; MacCormick R; Feld R; Yau JC
Cancer Treat Rep; 1987 Oct; 71(10):941-4. PubMed ID: 2820571
[TBL] [Abstract][Full Text] [Related]
18. [Polychemotherapeutic treatment in undifferentiated small cell carcinoma of the lung].
Illiano A; Giacomelli P; Tremiterra E; Scivicco S; Bariffi F; Olivieri D
Arch Monaldi; 1983; 38(1-2):53-7. PubMed ID: 6326702
[No Abstract] [Full Text] [Related]
19. Cyclic alternating chemotherapy for small cell carcinoma of the lung.
Murray N; Shah A; Wilson K; Goldie J; Voss N; Fryer C; Klimo P; Coy P; Hadzic E; Gudauskas G
Cancer Treat Rep; 1985 Nov; 69(11):1241-2. PubMed ID: 3004724
[TBL] [Abstract][Full Text] [Related]
20. The importance of dose and dose intensity in lung cancer chemotherapy.
Murray N
Semin Oncol; 1987 Dec; 14(4 Suppl 4):20-8. PubMed ID: 2825357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
